Latest news about Hemant Surgical Industries
Hemant Surgical Industries
600.00
-2.00(-0.33%)
Company Performance:
View Company Insights1D-0.33%
1M+28.14%
6M+102.46%
1Y+97.11%
5Y+234.17%
More news about Hemant Surgical Industries
20May 26
Hemant Surgical Industries Allots 6,49,600 Shares to Singularity Equity Fund 1 After Warrant Conversion
Hemant Surgical Industries has allotted 6,49,600 shares, equating to a 5% stake, to Singularity Equity Fund 1 (Madhusudan Kela) through warrant conversion. Following this allotment, Singularity Equity Fund 1's total shareholding in the company has risen to 6.9%. The transaction marks the completion of warrant conversion by the fund in Hemant Surgical Industries.
15May 26
Hemant Surgical Industries Reports Strong FY26 and Q4 Results; Net Profit More Than Doubles
Hemant Surgical Industries reported Q4 net profit of 128M Rupees versus 49M Rupees year-on-year, with revenue at 1.7B Rupees versus 576M Rupees and EBITDA at 158M Rupees versus 55M Rupees. For FY26, standalone net profit more than doubled to ₹1,823.34 lakhs from ₹813.21 lakhs, while revenue from operations surged to ₹23,098.71 lakhs from ₹10,652.66 lakhs, supported by a significant capital raise of ₹6,152.71 lakhs during the year.
07Apr 26
Hemant Surgical Industries Reports Full Demat Holdings for Q4 FY26
Hemant Surgical Industries Limited has confirmed full compliance with SEBI depositories regulations for Q4 FY26, with entire shareholding remaining in demat form and no rematerialisation requests received. The company submitted its Regulation 74(5) certificate to BSE on April 7, 2026, validated by registrar Bigshare Services Pvt. Ltd.
02Apr 26
Hemant Surgical Industries Partners with GBT Korea for C-ARM Technology Development
Hemant Surgical Industries Limited has executed a C-ARM Development and Supply Agreement with GBT Korea Co., Ltd. to develop and localize x-ray generators, electronic control systems, and c-arm imaging devices using fluoroscopy technology. The partnership aims to provide real-time high-resolution imaging for surgical orthopedic, trauma, and cardiovascular procedures. The agreement size remains confidential, and the transaction does not involve related party arrangements or special rights provisions.
01Apr 26
Hemant Surgical Signs Contract With Sonomed Escalon USA To Make Ophthalmic Devices
Hemant Surgical Industries Limited has entered into a strategic Semi Knocked Down manufacturing agreement with Sonomed Escalon, USA, focusing on ophthalmic ultrasound diagnostic devices. The partnership features preferential transfer pricing and a phased approach toward achieving complete localization with 100% manufacturing capabilities in India, positioning the company as a potential major player in the domestic ophthalmic diagnostic device market.
19Feb 26
Hemant Surgical Industries Secures ₹264.33 Crore Order from Central Medical Service Society
Hemant Surgical Industries Limited has secured a substantial purchase order worth ₹264.33 crores from the Central Medical Service Society for supply of Flat Panel Detectors, X-Ray generators, and related medical equipment. The orders dated December 2025 will be executed in tranches by September 30, 2026, with the company agreeing to commence interim supplies while final commercial terms are being finalized, highlighting the national importance of this healthcare infrastructure project.
12Nov 25
Hemant Surgical Industries Reports 31.5% Revenue Growth in H1 FY2026, Raises ₹61.53 Crore Through Share Issuance
Hemant Surgical Industries Limited announced unaudited financial results for H1 FY2026, reporting revenue of ₹64.26 crore, a 31.5% increase year-over-year. Basic EPS improved to ₹5.09 from ₹3.05. The company raised ₹61.53 crore through preferential allotment, allocating funds for expansion, working capital, debt repayment, and corporate purposes. As of September 30, 2025, ₹15.43 crore has been utilized, with ₹46.09 crore held in bank accounts.
22Sept 25
Hemant Surgical Industries Bolsters Promoter Stake with 600,000 Warrant Allotment
Hemant Surgical Industries Limited has approved the issuance of 600,000 convertible warrants to its promoters and promoter group. The warrants are equally distributed among three promoters: Hanskumar Shamji Shah, Hemant Praful Shah, and Kaushik Hanskumar Shah, each receiving 200,000 warrants. Each warrant is convertible into one fully paid-up equity share with a face value of Rs. 10 within 18 months from allotment. This move will increase the promoter holding from 73.56% to 64.67% of the total voting capital upon full conversion. The company's equity share capital post-acquisition will be Rs. 13,03,84,000, with a total diluted share capital of Rs. 15,13,76,000.
16Sept 25
Hemant Surgical Industries Allots 20.99 Lakh Warrants, Raises Rs. 10.34 Crores
Hemant Surgical Industries Limited (HSIL) has allotted 20,99,200 warrants on a preferential basis, raising Rs. 10.34 crores as an upfront payment. The warrants, priced at Rs. 197.00 each, were issued to both promoter and non-promoter entities. Each warrant is convertible into one equity share within 18 months. The company received 25% of the issue price upfront, with the remaining 75% payable upon conversion. This move could potentially alter HSIL's shareholding structure, with promoter shareholding expected to range from 15.42% to 29.72% post-conversion. The warrant issue complies with regulatory requirements and could lead to an additional capital raise of approximately Rs. 31.02 crores upon full conversion.
15Sept 25
Hemant Surgical Industries Secures Rs. 82.89 Crore Government Order for X-ray Machines
Hemant Surgical Industries has received a purchase order worth ₹82.89 crore from the Government of India for supplying X-ray machines. This significant contract is expected to boost the company's order book and strengthen its position in the medical equipment market. The deal showcases the company's expertise in medical imaging technology and could potentially lead to future collaborations in the public healthcare sector. This development may positively impact the company's financial performance and market reputation.
11Sept 25
Hemant Surgical Industries Secures Rs. 82.89 Crore Government Order for Portable X-ray Machines
Hemant Surgical Industries has received a ₹82.89 crore purchase order from the Central Medical Service Society, Ministry of Health and Family Welfare, Government of India. The company will supply Ultraportable Handheld portable X-ray Machines with related utilities. The order includes a 3-year warranty and is to be executed in tranches by December 31, 2025. This domestic order strengthens the company's position in the Indian medical equipment market, with no involvement from the promoter group or related party transactions.
28Aug 25
Hemant Surgical Industries Appoints New Independent Director, Accepts Resignation Due to Health Issues
Hemant Surgical Industries Limited has appointed Mr. Manish Kankani as a Non-Executive Independent Director for a five-year term, starting August 28, 2025. Mr. Kankani, a Chartered Accountant, brings 10 years of experience in auditing, taxation, and financial advisory, with expertise in NBFCs. The company also accepted the resignation of Mr. Ketan Chandrakant Dave due to health reasons. Additionally, the board approved the Directors' Report, scheduled the 36th AGM for September 23, 2025, and appointed auditors for the 2025-2026 financial year.
06Aug 25
Hemant Surgical Industries Unveils Rs. 92.59 Crore Fundraising Plan Through Preferential Issue
Hemant Surgical Industries Limited, a Mumbai-based medical equipment manufacturer, has approved a Rs. 92.59 crore fundraising plan through a preferential issue of equity shares and convertible warrants. The plan includes issuing 26 lakh equity shares at Rs. 197 per share to raise Rs. 51.22 crore, and 21 lakh convertible warrants at Rs. 197 each to raise Rs. 41.37 crore. Key investors include Wealthwave Capital Fund and Singularity funds. The company will also increase its authorized capital to Rs. 16 crore. An EGM is scheduled for August 30, 2025, for shareholder approval. Post-issuance, promoter shareholding is expected to decrease from 70.53% to 52.59%.
Industry Peers
Poly Medicure
Tarsons Products
Q-Line Biotech
Laxmi DentalHemant Surgical Industries
Vasa Denticity
Osel Devices
Fabtech Technologies
Prevest Denpro
QMS Medical Allied Services
1,583.80
(-0.35%)
326.85
(-3.31%)
598.30
(-2.18%)
190.80
(-3.47%)
600.00
(-0.33%)
444.00
(-4.31%)
355.20
(-2.34%)
132.11
(-1.82%)
388.15
(-1.23%)
170.77
(-0.15%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
